BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35367125)

  • 1. Isolated Ptosis Following a Vipera aspis Bite.
    Blasco Mariño R; Soteras Martínez I; Hernandez Roca AI; Zafren K
    Wilderness Environ Med; 2022 Jun; 33(2):245-247. PubMed ID: 35367125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary thrombosis after European adder bite in a patient on dual antiplatelet therapy: A case report.
    Bernasconi L; Schicchi A; Pirozzolo R; Negrini V; Scaravaggi G; Lonati D; Petrolini VM; Locatelli CA
    Toxicon; 2022 Dec; 220():106961. PubMed ID: 36347271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Guide to the Clinical Management of
    Di Nicola MR; Crevani M; Avella I; Cerullo A; Dorne JCM; Paolino G; Zattera C
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venomous snakebites.
    Adukauskienė D; Varanauskienė E; Adukauskaitė A
    Medicina (Kaunas); 2011; 47(8):461-7. PubMed ID: 22123554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envenomation by Vipera aspis in Piedmont (Italy): A report of three cases, including one case with neurological symptoms.
    Sassoè M
    Toxicon; 2023 Jul; 230():107154. PubMed ID: 37169267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vipers of Major clinical relevance in Europe: Taxonomy, venom composition, toxicology and clinical management of human bites.
    Di Nicola MR; Pontara A; Kass GEN; Kramer NI; Avella I; Pampena R; Mercuri SR; Dorne JLCM; Paolino G
    Toxicology; 2021 Apr; 453():152724. PubMed ID: 33610611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bites of venomous snakes in Switzerland].
    Plate A; Kupferschmidt H; Schneemann M
    Praxis (Bern 1994); 2016 Jun; 105(12):679-85; quiz 684-5. PubMed ID: 27269771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VENOMOUS SNAKEBITES IN CROATIA, CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT.
    Tunjić Pejak D; Nesek Adam V; Srzić I
    Acta Clin Croat; 2022 Jun; 61(Suppl 1):59-66. PubMed ID: 36304803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of Vipera aspis venom neurotoxicity.
    Ferquel E; de Haro L; Jan V; Guillemin I; Jourdain S; Teynié A; d'Alayer J; Choumet V
    PLoS One; 2007 Nov; 2(11):e1194. PubMed ID: 18030329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of a Vipera palaestinae envenomation objective findings associated with a complicated hospitalization course following a Vipera palaestinae bite.
    Koter N; Gat T; Furth M; Sadeh R; Galante O; Tomer O; Klein S; Muszkat M; Fuchs L; Nachshon A
    Toxicon; 2023 Oct; 234():107304. PubMed ID: 37778739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Systemic Envenomation Following Vipera berus Bite Managed with ViperaTAb Antivenom.
    Hamilton J; Kause J; Lamb T
    Wilderness Environ Med; 2019 Mar; 30(1):56-58. PubMed ID: 30385100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Assessment of a New Polyvalent Antivenom (Inoserp Europe) against Several Species of the Subfamily Viperinae.
    García-Arredondo A; Martínez M; Calderón A; Saldívar A; Soria R
    Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30841582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antivenom therapy for Vipera palaestinae bites in children: experience of two large, tertiary care pediatric hospitals.
    Pivko-Levy D; Munchnak I; Rimon A; Balla U; Scolnik D; Hoyte C; Voliovitch Y; Glatstein M
    Clin Toxicol (Phila); 2017 Apr; 55(4):235-240. PubMed ID: 28103732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of
    Kurtović T; Lang Balija M; Brvar M; Dobaja Borak M; Mateljak Lukačević S; Halassy B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33805701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation.
    Kurtović T; Brvar M; Grenc D; Lang Balija M; Križaj I; Halassy B
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27548220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snakebites in Hungary--epidemiological and clinical aspects over the past 36 years.
    Malina T; Krecsák L; Korsós Z; Takács Z
    Toxicon; 2008 May; 51(6):943-51. PubMed ID: 18241904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate-to-severe
    Lamb T; Stewart D; Warrell DA; Lalloo DG; Jagpal P; Jones D; Thanacoody R; Gray LA; Eddleston M
    Clin Toxicol (Phila); 2021 Nov; 59(11):992-1001. PubMed ID: 33720783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual neurotoxic envenomations by Vipera aspis aspis snakes in France.
    de Haro L; Robbe-Vincent A; Saliou B; Valli M; Bon C; Choumet V
    Hum Exp Toxicol; 2002 Mar; 21(3):137-45. PubMed ID: 12102539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye muscle paralysis after Vipera aspis envenomation.
    Re G; Trisolino G; Miglio F
    J Accid Emerg Med; 1999 Nov; 16(6):458. PubMed ID: 10572830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.